AMILI is a precision gut microbiome company that helps to advance microbiome research to address unmet and critical needs in healthcare.
AMILI's investors include Grab, East Ventures, TVM Capital Healthcare, Emtek Group, Vulcan Capital.
AMILI is headquartered in Singapore, Singapore.
AMILI is a precision gut microbiome company that helps to advance microbiome research to address unmet and critical needs in healthcare.
AMILI is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AMILI — Funding & Investors." VCBacked, May 29, 2023, https://www.vcbacked.co/company/amili. Accessed September 30, 2026.
VCBacked. (2023). AMILI — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/amili
{{cite web |title=AMILI — Funding & Investors |url=https://www.vcbacked.co/company/amili |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated